Risk of Safety Events Among Patients with UC and PsA Treated with Tofacitinib and Other Advanced Treatments in the United States

Study protocol

Initial protocol

A3921431 Non-Interventional Study Protocol v1.0 (PASS)_22 February 2023_Redacted

English (1005.83 KB - PDF) View document

Updated protocol

A3921431 Non-Interventional Study Protocol V3.0 18Nov2024.pdf

First published: 17/12/2025

English (243.52 KB - PDF) View document

Study results

A3921431_Komodo_PfizerNon-Interventional Study Report 25November2025_FINAL_Redacted.pdf

English (571.77 KB - PDF) View document

Study report

Abstract of study report

A3921431 Study Report Abstract_25Nov2025_Redacted.pdf

English (87.71 KB - PDF) View document

Other information

Study, other information

A3921431 Non Interventional PASS ABSTRACT 22Feb2023_Redacted

English (323.73 KB - PDF) View document

Secondary tabs